dilazep has been researched along with Diabetic Glomerulosclerosis in 8 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Excerpt | Relevance | Reference |
---|---|---|
"To determine whether the antiplatelet drug dilazep dihydrochloride affects the number of urinary podocytes in diabetic patients with microalbuminuria." | 5.09 | Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy. ( Ebihara, I; Hara, M; Koide, H; Nakamura, T; Sekizuka, K; Shimada, N; Ushiyama, C, 2000) |
"Diabetic nephropathy is a leading cause of end-stage renal disease in industrialized countries." | 1.31 | Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats. ( Amano, S; Inagaki, Y; Koga, K; Okamoto, T; Takeuchi, M; Yamagishi, S, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Zhou, H | 1 |
Mu, L | 1 |
Yang, Z | 1 |
Shi, Y | 1 |
Yamagishi, S | 1 |
Koga, K | 1 |
Inagaki, Y | 1 |
Amano, S | 1 |
Okamoto, T | 1 |
Takeuchi, M | 1 |
Nagai, T | 2 |
Tomizawa, T | 1 |
Mori, M | 1 |
Morikawa, A | 1 |
Eto, M | 1 |
Makino, I | 1 |
Koide, H | 2 |
Totsuka, Y | 1 |
Sugisaki, T | 1 |
Kitajima, T | 1 |
Ohmori, Y | 1 |
Kuriyama, S | 1 |
Oi, K | 1 |
Isogai, S | 1 |
Ohi, H | 1 |
Tomino, Y | 2 |
Yamamoto, M | 1 |
Fukui, M | 1 |
Kuramoto, T | 1 |
Kabuki, K | 1 |
Nakamura, T | 1 |
Ushiyama, C | 1 |
Shimada, N | 1 |
Sekizuka, K | 1 |
Ebihara, I | 1 |
Hara, M | 1 |
4 trials available for dilazep and Diabetic Glomerulosclerosis
Article | Year |
---|---|
The effect of pancreatic elastase on diabetic nephropathy.
Topics: Acetylglucosaminidase; Aged; Albuminuria; beta 2-Microglobulin; Blood Glucose; Blood Pressure; Body | 1994 |
Effect of pancreatic elastase on diabetic nephropathy.
Topics: Albuminuria; Blood Glucose; Blood Pressure; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diab | 1993 |
Clinical effect of the anti-platelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy--a multi-center study.
Topics: Adult; Aged; Albuminuria; Diabetic Nephropathies; Dilazep; Female; Humans; Male; Middle Aged; Platel | 1995 |
Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.
Topics: Albuminuria; Blood Pressure; Diabetic Nephropathies; Dilazep; Female; Humans; Male; Middle Aged; Pla | 2000 |
4 other studies available for dilazep and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy.
Topics: CD8-Positive T-Lymphocytes; Cell Death; Diabetes Mellitus; Diabetic Nephropathies; Dilazep; Genes, M | 2023 |
Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
Topics: Acetylglucosaminidase; Animals; Diabetic Nephropathies; Dilazep; Immunohistochemistry; Kidney; Male; | 2002 |
The effect of dilazep on urinary protein excretion in spontaneous diabetic Chinese hamster.
Topics: Animals; Basement Membrane; Cricetinae; Cricetulus; Diabetes Mellitus, Experimental; Diabetic Nephro | 1993 |
Effects of antiplatelet drug dilazep dihydrochloride on anionic sites and extracellular matrix (ECM) components in glomerular basement membrane of STZ-induced diabetic rats.
Topics: Animals; Anions; Basement Membrane; Binding Sites; Creatinine; Diabetes Mellitus, Experimental; Diab | 1995 |